The effects of concealment of epilepsy on medication adherence in people with epilepsy: A cross-sectional study

Basit Öğe Kaydı
dc.contributor.authorBuyukbayram, Zeliha
dc.contributor.authorAksoy, Meyreme
dc.contributor.authorYilmaz, Ridvan
dc.date.accessioned2024-12-24T19:27:03Z
dc.date.available2024-12-24T19:27:03Z
dc.date.issued2023
dc.departmentSiirt Üniversitesi
dc.description.abstractAim: Adherence to antiseizure medication is of great importance in achieving seizure control and maintaining well-being for people with epilepsy. Therefore, it is important to assess medication adherence and factors affecting medication adherence in this patient group. This study aims to examine the effects of concealment of epilepsy on medication adherence in people with epilepsy.Method: This cross-sectional study was conducted with 220 people with epilepsy. Data were collected using a patient information form, the Morisky Medication Adherence Scale-8 (MMAS-8), and the Concealment of Epilepsy Scale (CES) and analyzed using descriptive statistics and multiple linear regression analysis.Results: The mean age of the participants was 49.84 +/- 9.43 years, and 53.6% of them were male. Their mean MMAS-8 score was 4.25 +/- 1.99%, and 72.3% had low medication adherence. Additionally, their mean CES score was 49.84 +/- 9.43. The CES scores of the participants negatively predicted their MMAS-8 scores (p < 0.05), and medication adherence was positively predicted by female gender, the duration of diagnosis, the single administration of drugs per day, and employment status, whereas it was negatively predicted by the annual number of seizures (F=19.256, p < 0.001).Conclusion: In this study, people with epilepsy were found to have low medication adherence and a high tendency to conceal epilepsy. Furthermore, the tendency to conceal epilepsy had a negative effect on medication adherence.Implications: Psychosocial interventions aimed at reducing the tendency to conceal epilepsy can contribute to medication adherence in people with the condition.
dc.identifier.doi10.1016/j.eplepsyres.2023.107220
dc.identifier.issn0920-1211
dc.identifier.issn1872-6844
dc.identifier.pmid37699282
dc.identifier.scopus2-s2.0-85171790337
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.eplepsyres.2023.107220
dc.identifier.urihttps://hdl.handle.net/20.500.12604/6481
dc.identifier.volume196
dc.identifier.wosWOS:001074944500001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEpilepsy Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241222
dc.subjectEpilepsy
dc.subjectConcealment of disease
dc.subjectMedication adherence
dc.titleThe effects of concealment of epilepsy on medication adherence in people with epilepsy: A cross-sectional study
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu